Analyst Ratings for Medtronic, Inc. (MDT) [Buys]
MDT Rating Summary
MDT Price Target Summary
- Highest: $53.00 (Jefferies)
- Lowest: $36.00 (Goldman Sachs)
- Average: $46.27
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$46.27 (-11.1%)
Avg. $ Target:
$46.27 (-11.1%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 1/3/2013 | Mizuho Securities | Upgrade | Buy (Neutral) |
N/A (N/A) |
41.88 | 52.05 | 24.28% | Details |
| 8/17/2012 | Argus | Upgrade | Buy (Sell) |
N/A (N/A) |
40.47 | 52.05 | 28.61% | Details |
| 1/17/2012 | Wells Fargo | Upgrade | Outperform (N/A) |
45.00 (N/A) |
38.65 | 52.05 | 34.67% | Details |
| 11/23/2011 | BofA/Merrill Lynch | Upgrade | Buy (N/A) |
N/A (N/A) |
33.27 | 52.05 | 56.45% | Details |
| 6/15/2011 | Brean Capital » Updated 2/22/2012 |
New Coverage | Buy (N/A) |
47.00 (N/A) |
38.40 | 52.05 | 35.55% | Details |
| 12/22/2010 | UBS » Updated 9/20/2012 |
Upgrade | Buy (N/A) |
48.00 (46.00) |
36.92 | 52.05 | 40.98% | Details |
| 12/17/2010 | Bernstein | Upgrade | Outperform (N/A) |
N/A (N/A) |
36.18 | 52.05 | 43.86% | Details |
| 7/12/2010 | BMO Capital | Upgrade | Outperform (N/A) |
N/A (N/A) |
37.23 | 52.05 | 39.81% | Details |
